Adial Pharmaceuticals ADIL
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 1.01 | 4 | -41.62 | -2 | -35.23 | 5 |
| 2024Q3 | 1.00 | 6 | -43.15 | -2 | -37.59 | 7 |
| 2024Q2 | 1.15 | 4 | -47.27 | -2 | -42.26 | 5 |
| 2024Q1 | 1.33 | 6 | -126.93 | -6 | -113.42 | 7 |
| 2023Q4 | 1.86 | 4 | -59.79 | -2 | -50.50 | 5 |
| 2023Q3 | 2.78 | 2 | -48.97 | -1 | -41.68 | 3 |
| 2023Q2 | 5.21 | 3 | 45.74 | 1 | 28.33 | 4 |
| 2023Q1 | 8.75 | 1 | -123.24 | -3 | -60.32 | 4 |
| 2022Q4 | 5.38 | 3 | -66.02 | -3 | -42.55 | 6 |
| 2022Q3 | 8.75 | 5 | -46.51 | -3 | -33.31 | 8 |
| 2022Q2 | 33.50 | 8 | -41.23 | -4 | -30.92 | 11 |
| 2022Q1 | 50.25 | 11 | -40.91 | -3 | -27.13 | 14 |
| 2021Q4 | 67.50 | 4 | -108.91 | -6 | -65.07 | 7 |
| 2021Q3 | 107.25 | 7 | -71.79 | -4 | -46.66 | 10 |
| 2021Q2 | 63.75 | 5 | -85.02 | -4 | -53.22 | 8 |
| 2021Q1 | 60.50 | 6 | -100.67 | -5 | -68.49 | 9 |
| 2020Q4 | 42.50 | 4 | -62.67 | -3 | -50.76 | 5 |
| 2020Q3 | 55.75 | 7 | -42.02 | -3 | -37.80 | 8 |
| 2020Q2 | 34.75 | 9 | -25.25 | -2 | -23.50 | 9 |
| 2020Q1 | 32.50 | 6 | -35.88 | -2 | -33.43 | 6 |